Blockchain Digital Label Management for Drug Lifecycle Tracking

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current drug label management systems face challenges such as manual updates, version control issues, and the inability to track digital labels throughout their lifecycle, from clinical trials to distribution and beyond.

Innovation Solution

A blockchain-based digital label management system that uses artificial intelligence to track the lifecycle of a drug, including clinical trials, regulatory approval, and distribution, and allows for real-time updates to digital labels via QR codes linked to a blockchain URL.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If manual updates are used for digital labels, then flexibility in content modification is maintained, but error rate increases and update efficiency decreases

Engineering Contradiction:

Improvelabel update efficiencyVSAvoidupdate accuracy

Core Design Contradiction:

ProductivityVSReliability

Solution Approach 1:

The system enables automatic label updates through AI-generated content and blockchain-verified transactions. The digital label system self-updates by receiving verified information from the blockchain network, eliminating manual intervention and its associated errors while maintaining high efficiency through automated processes.

Inventive Principle:

Principle #25Self-service

Solution Approach 2:

The system implements a feedback mechanism where label updates are verified against blockchain records and AI-generated data. This closed-loop verification process ensures update accuracy by comparing new label content with verified source data before deployment, preventing errors while maintaining rapid update cycles.

Inventive Principle:

Principle #23Feedback

2Loss of information

If traditional version control systems are used, then tracking changes is possible, but transparency and accountability across the lifecycle are insufficient

Engineering Contradiction:

Improvelabel version trackingVSAvoidlifecycle accountability

Core Design Contradiction:

Loss of informationVSReliability

Solution Approach 1:

The system introduces blockchain as an intermediary layer between label versions and stakeholders. Each label update is recorded on the blockchain with immutable timestamps and verification data, creating a transparent audit trail that enhances accountability while maintaining complete version tracking capability.

Inventive Principle:

Principle #24Intermediary (Mediator)

3Loss of time

If digital labels are updated in real-time, then information currency is improved, but system complexity increases

Engineering Contradiction:

Improveinformation freshnessVSAvoidupdate system complexity

Core Design Contradiction:

Loss of timeVSDevice complexity

Solution Approach 1:

The system replaces complex manual update mechanisms with AI-generated content and blockchain-verified transactions. This substitution automates the label update process, achieving real-time information currency while actually reducing operational complexity by eliminating manual procedures and centralized coordination requirements.

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

Data Source

PatentUS12271435B2Digital label management

Publication Date: 2025.04.08 IQVIA INC

AI summary

Embodiments of the present disclosure provide a method for monitoring/tracking the lifecycle of a drug from build (e.g., as part of clinical trial development), to approval (e.g., regulatory), to in-market (e.g., distribution and safety information). The use of artificial intelligence (AI) and blockchain technology may enable the system to track the drug down to the prescription level and may support a digital label that can be updated as necessary based on such monitoring (e.g., that can be amended based on safety information detected while the drug is in market and warnings sent out upon amendment).